Martin Witzenrath

17.8k total citations · 2 hit papers
182 papers, 5.0k citations indexed

About

Martin Witzenrath is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Martin Witzenrath has authored 182 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 63 papers in Pulmonary and Respiratory Medicine and 40 papers in Immunology. Recurrent topics in Martin Witzenrath's work include Pneumonia and Respiratory Infections (43 papers), Respiratory Support and Mechanisms (25 papers) and Immune Response and Inflammation (19 papers). Martin Witzenrath is often cited by papers focused on Pneumonia and Respiratory Infections (43 papers), Respiratory Support and Mechanisms (25 papers) and Immune Response and Inflammation (19 papers). Martin Witzenrath collaborates with scholars based in Germany, United States and United Kingdom. Martin Witzenrath's co-authors include Norbert Suttorp, Simone Rosseau, Stefan Hippenstiel, Bastian Opitz, Birgitt Gutbier, Katrin Reppe, Bernd Schmeck, Jasmin Lienau, Christoph Tabeling and Andreas C. Hocke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Martin Witzenrath

168 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation

2006 741 citations Martin Witzenrath, Simone Rosseau et al. profile →
European Respiratory Society statement on long COVID follow-up

2022 102 citations Martin Witzenrath et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Witzenrath Germany	39	1.8k	1.2k	1.1k	1.0k	522	182	5.0k
Simone Rosseau Germany	37	1.2k 0.6×	1.2k 1.0×	1.4k 1.2×	1.4k 1.4×	341 0.7×	94	5.0k
Timothy R. Crother United States	38	3.0k 1.7×	815 0.7×	2.1k 1.8×	805 0.8×	513 1.0×	81	5.6k
Joris J. T. H. Roelofs Netherlands	44	1.7k 0.9×	1.7k 1.4×	1.7k 1.5×	1.3k 1.3×	747 1.4×	271	7.3k
Sylvia Knapp Austria	48	1.5k 0.8×	1.6k 1.4×	2.8k 2.5×	1.1k 1.1×	561 1.1×	135	6.2k
Cornelis van ′t Veer Netherlands	38	1.1k 0.6×	1.1k 0.9×	2.0k 1.7×	588 0.6×	364 0.7×	120	5.5k
Bernd Schmeck Germany	41	2.1k 1.2×	1.3k 1.1×	2.0k 1.7×	675 0.7×	513 1.0×	145	5.1k
Cynthia C. Nast United States	51	2.4k 1.3×	953 0.8×	1.6k 1.4×	797 0.8×	1.3k 2.6×	152	7.7k
Jaklien C. Leemans Netherlands	40	2.1k 1.2×	1.0k 0.9×	2.1k 1.9×	599 0.6×	428 0.8×	101	5.5k
Judith Hellman United States	32	1.1k 0.6×	1.1k 0.9×	1.4k 1.3×	395 0.4×	416 0.8×	78	4.0k
Joseph P. Mizgerd United States	47	1.8k 1.0×	1.4k 1.2×	3.0k 2.6×	1.1k 1.1×	589 1.1×	114	6.3k

Countries citing papers authored by Martin Witzenrath

Since Specialization

Citations

This map shows the geographic impact of Martin Witzenrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Witzenrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Witzenrath more than expected).

Fields of papers citing papers by Martin Witzenrath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Witzenrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Witzenrath. The network helps show where Martin Witzenrath may publish in the future.

Co-authorship network of co-authors of Martin Witzenrath

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Witzenrath. A scholar is included among the top collaborators of Martin Witzenrath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Witzenrath. Martin Witzenrath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Staß, Heino, Victor M. Corman, Nils C. Gassen, et al.. (2025). Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial. PLoS ONE. 20(2). e0303924–e0303924.

Krautwurst, Sebastian, Christine H. Rohde, Geraldine Nouailles, et al.. (2025). Phage–phage competition and biofilms affect interactions between two virulent bacteriophages and Pseudomonas aeruginosa. The ISME Journal. 19(1). 4 indexed citations

Shen, Dacheng, Ling Yao, Bastian Opitz, et al.. (2024). Semisynthetic Glycoconjugate Vaccine Lead against Klebsiella pneumoniae Serotype O2afg Induces Functional Antibodies and Reduces the Burden of Acute Pneumonia. Journal of the American Chemical Society. 146(51). 35356–35366. 2 indexed citations

Steinbeis, Fridolin, Claudia Kedor, Charlotte Thibeault, et al.. (2024). A new phenotype of patients with post-COVID-19 condition is characterised by a pattern of complex ventilatory dysfunction, neuromuscular disturbance and fatigue symptoms. ERJ Open Research. 10(5). 1027–2023. 1 indexed citations

Timm, Sara, Jan Hegermann, Diana Fatykhova, et al.. (2023). The unremarkable alveolar epithelial glycocalyx: a thorium dioxide-based electron microscopic comparison after heparinase or pneumolysin treatment. Histochemistry and Cell Biology. 160(2). 83–96. 5 indexed citations

Rovas, Alexandros, et al.. (2023). Analysis of Urinary Glycosaminoglycans to Predict Outcome in COVID-19 and Community-Acquired Pneumonia—A Proof-of-Concept Study. Journal of Clinical Medicine. 12(16). 5269–5269. 3 indexed citations

Thibeault, Charlotte, Kanika Vanshylla, Veronica Di Cristanziano, et al.. (2023). Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19. JCI Insight. 8(8). 2 indexed citations

Kirsten, Holger, Gitta Anne Heinz, Mir‐Farzin Mashreghi, et al.. (2023). MicroRNA-223 Dampens Pulmonary Inflammation during Pneumococcal Pneumonia. Cells. 12(6). 959–959. 6 indexed citations

Wienhold, Sandra-Maria, Baptiste Gaborieau, Holger Ziehr, et al.. (2023). Repetitive Exposure to Bacteriophage Cocktails against Pseudomonas aeruginosa or Escherichia coli Provokes Marginal Humoral Immunity in Naïve Mice. Viruses. 15(2). 387–387. 13 indexed citations

10.

Steinbeis, Fridolin, Cian M. Scannell, Jennifer Erley, et al.. (2022). Brief Research Report: Quantitative Analysis of Potential Coronary Microvascular Disease in Suspected Long-COVID Syndrome. Frontiers in Cardiovascular Medicine. 9. 877416–877416. 7 indexed citations

11.

Kurth, Florian, Elisa T. Helbig, Lena J. Lippert, et al.. (2022). Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial. Journal of Global Antimicrobial Resistance. 32. 44–47. 8 indexed citations

12.

Letsiou, Eleftheria, Jasmin Lienau, Holger Müller-Redetzky, et al.. (2022). Ventilator-induced Lung Injury Is Modulated by the Circadian Clock. American Journal of Respiratory and Critical Care Medicine. 207(11). 1464–1474. 17 indexed citations

13.

Gutbier, Birgitt, et al.. (2021). Efficacy and safety of intratracheal IFN-γ treatment to reverse stroke-induced susceptibility to pulmonary bacterial infections. Journal of Neuroimmunology. 355. 577568–577568. 2 indexed citations

14.

Rosołowski, Maciej, Volker Oberle, Peter Ahnert, et al.. (2020). Dynamics of cytokines, immune cell counts and disease severity in patients with community-acquired pneumonia – Unravelling potential causal relationships. Cytokine. 136. 155263–155263. 9 indexed citations

15.

Gutbier, Birgitt, Katrin Reppe, Ansgar Santel, et al.. (2018). Prognostic and Pathogenic Role of Angiopoietin-1 and -2 in Pneumonia. American Journal of Respiratory and Critical Care Medicine. 198(2). 220–231. 46 indexed citations

16.

Schumann, Benjamin, Heung Sik Hahm, Sharavathi G. Parameswarappa, et al.. (2017). A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Science Translational Medicine. 9(380). 71 indexed citations

17.

Tabeling, Christoph, Liming Wang, Neil M. Goldenberg, et al.. (2015). CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction. Proceedings of the National Academy of Sciences. 112(13). E1614–23. 72 indexed citations

18.

Wang, Liming, Jun Yin, Arata Tabuchi, et al.. (2012). Hypoxic pulmonary vasoconstriction requires connexin 40–mediated endothelial signal conduction. Journal of Clinical Investigation. 122(11). 4218–4230. 101 indexed citations

19.

Müller, Holger C., Katharina Hellwig, Simone Rosseau, et al.. (2010). Simvastatin attenuates ventilator-induced lung injury in mice. Critical Care. 14(4). R143–R143. 59 indexed citations

20.

Schütte, Hartwig, Konstantin Mayer, Heiko Bürger, et al.. (2001). Endogenous Nitric Oxide Synthesis and Vascular Leakage in Ischemic-Reperfused Rabbit Lungs. American Journal of Respiratory and Critical Care Medicine. 164(3). 412–418. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact